BioVie (OTCQB: BIVI)
About
Management & Directors
Medical advisory board
Clinical Team
Consultant network
Disease Target
Ascites
Severe complications
Current drug therapies
How does ascites develop?
Technology
BIV201 development status
Future possibilities
Potential access to early-stage compounds
Efflux pump antibiotics program
Forward looking statements
Investors
Financial Information
Press Releases
Contact
Contact Us
Search
Subscribe to Our Email List
Be the first to receive breaking news!
Scroll to top